Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer

Breast care

Andrea Rottenfusser¹  Robert M. Mader¹  Anna S. Berghoff¹  Michael Gnant¹  Elisabeth Bergen¹  Catharina De Vries¹  Matthias Preusser¹  Claudia Sattlberger¹  Flora Zagouri¹  Rupert Bartsch¹  Peter Dubsky¹  Florian Fitzal¹  Cornelia Sparber¹  Christoph C. Zielinski¹  Guenther G. Steger¹  Margaretha Rudas¹ 

[1] aComprehensive Cancer Center Vienna, Medical University of Vienna, Austria

关键词: Brain metastases;    Metastatic breast cancer;    HER2-positive breast cancer;    Oral vinorelbine;    Taxanes;    Trastuzumab;   

DOI  :  10.1159/000368330

学科分类：泌尿医学

来源: S Karger AG

【 摘 要 】

This retrospective analysis was planned as a direct comparison of taxanes plus trastuzumab to the less toxic combination of oral vinorelbine (OV) plus trastuzumab as a first-line therapy for metastatic HER2-positive breast cancer.

【 授权许可】

Unknown